ATXN3 and neoplasm: Importantly, stable expression of PD-L1 on ATXN3-null LLC1 cells partially recovered the syngeneic tumor growth (Figure 4U), indicating that ATXN3 potentiates tumor evasive function through, at least in part, PD-L1–mediated suppression of antitumor immunity.